Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
Is This Footwear Brand Facing Trouble with Its Debt Strategy?
Consumer Stocks

Is This Footwear Brand Facing Trouble with Its Debt Strategy?

Is This Footwear Brand Facing Trouble with Its Debt Strategy?

Is Brookfield Renewable's Capital Use Strategy Falling Behind?
Utility Stocks

Is Brookfield Renewable's Capital Use Strategy Falling Behind?

Is Brookfield Renewable's Capital Use Strategy Falling Behind?

Is Blackstone’s Capital Return Losing Momentum Compared To Peers?
Financial Stocks

Is Blackstone’s Capital Return Losing Momentum Compared To Peers?

Is Blackstone’s Capital Return Losing Momentum Compared to Peers?

Is PulteGroup’s Capital Return Falling Behind Industry Trends?
Real Estate

Is PulteGroup’s Capital Return Falling Behind Industry Trends?

Is PulteGroup’s Capital Return Falling Behind Industry Trends?

Is Ford’s Return Efficiency Lagging In The Automotive Industry?
Consumer Stocks

Is Ford’s Return Efficiency Lagging In The Automotive Industry?

Is Ford’s Return Efficiency Lagging in the Automotive Industry?

Is Lowe’s Retail Model Falling Behind Competitors Now?
Consumer Stocks

Is Lowe’s Retail Model Falling Behind Competitors Now?

Is Lowe’s Retail Model Falling Behind Competitors Now?

Is Motorola Solutions Missing Key Market Signals In Tech?
Technology Stocks

Is Motorola Solutions Missing Key Market Signals In Tech?

Is Motorola Solutions Missing Key Market Signals in Tech?

Is Ternium’s Dividend Strategy Aligned With Market Trends?
Basic Materials

Is Ternium’s Dividend Strategy Aligned With Market Trends?

Is Ternium’s Dividend Strategy Aligned With Market Trends?

Will Pfizer approach Viking Therapeutics with a buyout proposal?
Healthcare

Will Pfizer approach Viking Therapeutics with a buyout proposal?

Investors are running into Viking Therapeutics (NASDAQ: VKTX) this week after an incident of drug-induced liver injury pushed Pfizer (NYSE: PFE) into terminating the development of its weight-loss pill. Viking’s share price has gained % in recent sessions on speculation that PFE will now resort to an acquisition to expand its footprint in the weight-loss […]

  • April 15, 2025 12:26 PM PDT
  • Invezz
Is Revvity's Recent Performance Reflective Of Its Market Position?
Healthcare Stocks

Is Revvity's Recent Performance Reflective Of Its Market Position?

Is Revvity's Recent Performance Reflective Of Its Market Position?

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.